A61K 9/5021
Organic macromolecular compounds
Official title: {Organic macromolecular compounds}
A61K9/5021 (Organic macromolecular compounds) appears on 3,540 US grants and 5,764 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,540
- Published applications
- 5,764
- Assignees
- 2,255
- Inventors
- 9,741
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 5 | 0 |
| 1978 | 4 | 0 |
| 1979 | 7 | 0 |
| 1980 | 11 | 0 |
| 1981 | 2 | 0 |
| 1982 | 14 | 0 |
| 1983 | 11 | 0 |
| 1984 | 10 | 0 |
| 1985 | 7 | 0 |
| 1986 | 11 | 0 |
| 1987 | 21 | 0 |
| 1988 | 19 | 0 |
| 1989 | 39 | 0 |
| 1990 | 40 | 0 |
| 1991 | 27 | 0 |
| 1992 | 30 | 0 |
| 1993 | 35 | 0 |
| 1994 | 39 | 0 |
| 1995 | 43 | 0 |
| 1996 | 47 | 0 |
| 1997 | 63 | 0 |
| 1998 | 53 | 0 |
| 1999 | 40 | 0 |
| 2000 | 39 | 0 |
| 2001 | 53 | 22 |
| 2002 | 55 | 85 |
| 2003 | 85 | 136 |
| 2004 | 52 | 151 |
| 2005 | 36 | 162 |
| 2006 | 46 | 174 |
| 2007 | 33 | 196 |
| 2008 | 25 | 184 |
| 2009 | 26 | 170 |
| 2010 | 54 | 216 |
| 2011 | 42 | 198 |
| 2012 | 91 | 175 |
| 2013 | 106 | 226 |
| 2014 | 172 | 294 |
| 2015 | 169 | 334 |
| 2016 | 185 | 356 |
| 2017 | 210 | 342 |
| 2018 | 182 | 279 |
| 2019 | 214 | 310 |
| 2020 | 181 | 301 |
| 2021 | 201 | 280 |
| 2022 | 153 | 277 |
| 2023 | 133 | 243 |
| 2024 | 153 | 277 |
| 2025 | 159 | 229 |
| 2026 | 100 | 147 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of forming an encapsulated core material, an encapsulated material, compositions uses thereof6 Oct 2026US 12,751,902 B2
- Prolonged-release pharmaceutical composition for oral administration of sultiame6 Oct 2026US 12,751,928 B2Advicenne
- Injectable formulations in a method for treating pain6 Oct 2026US 12,751,943 B2Pelthos Therapeutics Inc.
- Herbal bioactives based immunostimulant formulation for poultry birds and cattle and preparation thereof15 Sep 2026US 12,734,134 B2Edhas Technologies Inc.
- Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics8 Sep 2026US 12,728,110 B2Flamel Ireland Limited
- Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof1 Oct 2026US 2026/0294817 A1Impax Laboratories, LLC
- Pharmaceutical composition comprising glp-1 receptor agonist, gip/glp-1 receptor agonist and/or glp-1/gip/gcg receptor triple agonist1 Oct 2026US 2026/0294819 A1Aulbio Co., Ltd.
- Hydrogel and orexin receptor ligand compositions and methods of making and using the same1 Oct 2026US 2026/0294820 A1Biologic Delivery Technologies LLC
- Magnetically drivenable antigen delivery unit and method of forming same1 Oct 2026US 2026/0294821 A1City University of Hong Kong
- Systems and methods to provide therapeutic factor viii using ultrasound-mediated nucleic acid delivery1 Oct 2026US 2026/0295083 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
Most cited
By later US patents
- Controlled release formulations coated with aqueous dispersions of acrylic polymers1,011US 5,639,476 AEuro-Celtique S. A. · 1997
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Encapsulation of biological material667US 4,352,883 ADamon Corporation · 1982